To investigate the influence of obesity on the regulation of myocardial glucose metabolism following protein kinase C (PKC) activation in obese (fa=fa) and lean (Fa=?) Zucker rats. DESIGN: Isolated hearts obtained from 17-week-old lean and obese Zucker rats were perfused with 200 nM phorbol 12-myristate 13-acetate (PMA) for different time periods prior to the evaluation of PKC and GLUT-4 translocation. For metabolic studies isolated hearts from 48 h starved Zucker rats were perfused with an erythrocytes-enriched buffer containing increased concentrations (10 -100 nM) of PMA. H]glucose, respectively. RESULTS: PMA (200 nM) induced maximal translocation of ventricular PKCa from the cytosol to the membranes within 10 min. This translocation was 2-fold lower in the heart from obese rats when compared to lean rats. PMA also induced a significant translocation of ventricular GLUT-4 from the microsomal to the sarcolemmal fraction within 60 min in lean but not in obese rats. Rates of basal cardiac glucose oxidation and glycolysis in obese rats were approximately 2-fold lower than those of lean rats. Perfusion with increasing concentrations of PMA (10 -100 nM) led to a significant decrease of cardiac glucose oxidation in lean but not in obese rats. CONCLUSION: Our results show that in the heart of the genetically obese Zucker rat, the impairment in PKCa activation is in line with a diminished activation of GLUT-4 as well as with the lack of PMA effect on glucose oxidation.
Introduction
The genetically obese Zucker rat is viewed as a model of severe obesity, associated with insulin resistance and impaired glucose tolerance. 1, 2 In these animals, insulin-stimulated glucose uptake into cardiac and skeletal muscles is markedly decreased, 3, 4 and insulin fails to recruit the predominant glucose transporter isoform GLUT-4. 5, 6 Obese Zucker rats also exhibit diminished glucose uptake, glucose oxidation 7 and incorporation of glucose into glycogen 8 as well as differences in protein turnover and amino acid metabolism. 9 Moreover, in the obese Zucker rat expression of protein kinase C (PKC) in soleus muscle 10 as well as activation of PKC in response to hormones or phorbol esters, was found to be diminished in the heart 11 and in hepatocytes 12,13 when compared to lean rats.
PKC is a family of serine-threonine kinases that is involved in intracellular transducing signals generated by various hormones and growth factors, 14, 15 playing an important regulatory role in a variety of biological phenomena. This kinase family has also been shown to be involved in the translocation of glucose transporters (GLUT) and=or regulation of glucose uptake in the heart 11 and skeletal muscle cells 16, 17 and adipocytes. 18 Moreover, activation of PKC is suggested to be involved in the regulation of proteins controlling glucose oxidation 19 and glycogen metabolism.
However, at the present time there is scant information linking the myocardial metabolism of glucose to the activation of the PKC signaling pathway. Therefore, we investigated whether PKC is involved in the regulation of the cardiac glucose metabolism and whether obesity influences this regulation. For this purpose we perfused isolated hearts from lean and obese Zucker rats with the PKC activator phorbol 12-myristate 13-acetate (PMA) and determined activation of PKCa and GLUT-4 as well as the rate of glucose oxidation and glycolysis.
Materials and methods

Animals
Female 17-week-old Zucker rats were graciously provided by Professor B Jeanrenaud (Medical Research Foundation, Geneva, Switzerland). Animals were fed a standard laboratory chow ad libitum and had free access to water.
The investigations conform with the guide for the care and use of laboratory animals published by the US National Institute of Health (NI publication no. 85-23, revised 1996) and were approved by the Institutional Ethical Committee for Animal Experiments and the Swiss Federal Office for Veterinary Medicine.
Isolated heart preparation and perfusion Determination of subcellular distribution of PKCa and GLUT-4. Rats which had free access to standard laboratory chow prior to the experiments were anesthetized with thiopental sodium (0.2 ml=100 g i.p.; 5% pentothal, Abbott Laboratories, Chicago, IL, USA), a thoracotomy was performed and 1000 IU heparin (Liquemin, Roche, Basel, Switzerland) was injected into the inferior vena cava before excision of the heart, which was placed in ice-cold saline, blotted and weighed. The aorta was mounted onto a canula and retrograde perfusion was done at a constant flow in a non-recirculating system. The flow in the system was controlled by a roller pump (model IPN-8, Ismatec, Glattbrugg, Switzerland). Perfusate was Krebs -Henseleit buffer (KHbuffer) containing 123 mM NaCl, 4 mM KCl, 1.8 mM CaCl 2 , 1.4 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 20 mM NaHCO 3 and 11 mM glucose. KH-buffer was equilibrated with 95% O 2 -5% CO 2 and warmed to 37 C. After an equilibration time of 10 min, control hearts were perfused with KH-buffer during different time-periods while stimulated hearts were perfused with the same buffer containing 200 nM phorbol PMA, (Alexis, San Diego, CA, USA) during the same time-periods.
At the end of the perfusion protocol, the ventricles were cut and immediately homogenized in buffer A (see next paragraph for more details), or immediately frozen in liquid nitrogen and stored at 7 70 C for subsequent analysis.
Determination of cardiac glucose oxidation and glycolysis. In contrast to the translocation studies evaluating early cellular events, in metabolic studies the interaction of multiple factors has to be taken into consideration. To obtain the best possible standardization and to keep insulin blood levels as low as possible, rats were fasted for 48 h prior to the metabolic experiments. The hearts were isolated, prepared and perfused with an erythrocytes-enriched buffer (EEbuffer) as described in detail previously. 21, 22 Experiments for determination of glucose oxidation and glycolysis were performed with perfusate containing 8 mM glucose and 0.4 mM palmitate. 23 Glucose uptake is unlikely to be maximal in the conditions used for determination of glycolysis because palmitate provides an alternative substrate, but Montessuit et al 21, 23 have shown this setting to be adequate for measuring both glucose oxidation and glycolysis. For the measurement of glucose oxidation and glycolysis, the perfusate contained 40 mCi=l of [U- 14 C]glucose and 50 mCi=l [5- 3 H]glucose (Amersham Rahn, Zürich, Switzerland). A fluid-filled latex balloon, connected to a pressure transducer (Statham P21XL, Gould Inc., Valley View, OH, USA) was inserted into the left ventricle. The filling of the balloon was kept constant. Isovolumetric left ventricular diastolic and systolic pressures were recorded continuously on a strip chart recorder (model 2400S, Gould). Since pressure developed by the heart is an important determinant of myocardial oxidative rates, filling of the balloon was adjusted at the beginning of the experiment to give a systolic pressure of 75 mmHg. Hearts were paced at 300 beats=min throughout the experiment. To correct for variations of overall oxidative metabolism (variations of developed left ventricular pressure, DLVP) independent of PMA, glucose oxidation was divided by the consumption of oxygen at each time-point, and results were expressed as the percent of control (value obtained at the end of the stabilization period).
Following 60 min of control perfusion, hearts were submitted to increasing concentrations of PMA (10 -100 nM). After 60 min of control perfusion, we added 10 nM PMA, followed by concentrations of 30 and 100 nM PMA, 30 and 60 min, respectively, after the first PMA addition. Samples were taken for analysis prior to each addition of PMA. PMA concentrations higher than 100 nM were not used, since higher doses can cause vasoconstriction which in the working heart perfused with viscous fluid, due to the presence of erythrocytes, causes ischemia.
To ensure consistency in comparing data of lean and obese rats, we always perfused hearts from both groups on the same day.
Analytical procedures
Rates of glucose oxidation and glycolysis were determined based on measurement of the myocardial release of 
21,23
Plasma concentrations of non-esterified fatty acids (NEFA) were measured by the method of Duncombe (NEFA C kit, Wako Pure Chemical, Osaka, Japan). 24 Plasma samples were
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Preparation of subcellular fractions
Preparation of cytosolic and particulate fractions. Minced cardiac ventricles were homogenized in 2 vols of ice-cold buffer A (pH 7.45, containing 20 mM Tris base, 2 mM EDTA Titriplex, 10 mM EGTA, 0.25 M saccharose, 10 mM DTT, 55 mM leupeptin) with a Dounce homogenizer. Homogenates were centrifuged at 100 000 g for 1 h. The supernatant was used as the cytosolic fraction. The pellet was resuspended in buffer A containing 1% (v=v) Triton X-100 and incubated for 30 min at room temperature, before being diluted with buffer A to obtain a final concentration of 0.2% of Triton X-100. The homogenate was centrifuged at 100 000 g for 1 h and the supernatant obtained was used as the particulate fraction. The cytosolic and membrane fractions were analyzed within 12 h for the presence of PKCa (Western blot analysis).
Preparation of sarcolemmal and microsomal fractions.
Sarcolemmal and microsomal fractions were isolated by a differential centrifugation protocol as described previously. 21 The sarcolemmal marker enzyme Na þ =K þ -ATPase was enriched 7 -8-fold in the sarcolemmal fraction but was not significantly enriched in the microsomal fraction (n ¼ 26). Na þ =K þ -ATPase enrichment was not affected by PMA.
Protein assay
Protein contents of homogenate or subcellular fractions were determined using a Lowry protein assay detergent compatible kit (Bio-Rad, Hercules, CA, USA).
Western blots analysis for PKCa and GLUT-4 localization
The following antibodies were used: anti-PKCa and antibodies (Transduction Laboratories, Lexington, KY, USA); monoclonal anti-GLUT-4 antibody; clone 1F8 (Anawa, Wangen, Zürich, Switzerland); anti-Na þ =K þ -ATPase a1 subunit antibody (Upstate Biotechnology, Lake Placid, NY, USA); antiPKCd and e anitbodies, anti-mouse secondary antibody (Santa Cruz, Biotechnology, Santa Cruz, CA, USA); rabbit anti-mouse IgG (Sigma, Buchs, Switzerland); anti-rabbit antibody (Covalab, France). Western blots were performed according to standard methods, using antibody dilutions as described previously. 25 Myocardial content of GLUT-4 protein in the sarcolemmal and the microsomal membrane fraction and the enrichment of GLUT-4 in the sarcolemmal fraction were evaluated as described. 26 To ensure consistency in data analysis, the cytosolic and particulate fractions of the PMA-stimulated heart and the control-heart of lean and obese rats were run on the same gel.
Statistical analysis
Quantitative data were described as mean AE s.e.m., and statistical analysis was performed using unpaired Student t-test or one-way analysis of variance (ANOVA) test when appropriate. Glucose metabolism data were analyzed by multifactorial analysis of variance (MANOVA); time, PMA treatment and rat genotypes being considered as factors. Differences were considered significant at P-value less than 0.05.
Results
Characterization of the animals
The weight of obese (fa=fa), 17-week-old Zucker rats was 380 AE 2 g (n ¼ 101), whereas that of age-matched lean controls (Fa=?) rats was 220 AE 3 g (n ¼ 118). Hearts of lean rats weighed 1.3 AE 0.02 (n ¼ 123) and those of obese rats 1.5 AE 0.02 (n ¼ 100). Both body and cardiac weights of obese fa=fa rats were significantly higher than those of lean rats (P < 0.001). Plasma glucose concentration in 48 h-fasted obese Zucker rats was significantly higher compared to that of lean ones (13.9 AE 0.8 vs 8.8 AE 0.8 mmol=l, respectively; P < 0.0001, n ¼ 11 -12). Plasma triglyceride concentrations were slightly but not significantly higher in obese rats (obese rats, 0.69 AE 0.11 vs lean rats, 0.50 AE 0.08 mmol=l, n ¼ 8 -10).
PMA-induced translocation of PKCa
The subcellular distribution of ventricular PKCa, d, e and z was determined in hearts of lean and obese rats perfused for 10 and 30 min with either KH-buffer alone or with 200 nM PMA. Perfusing isolated heart from lean rats with PMA concentrations from 10 -300 nM, we observed a maximal translocation of PKCa from the cytosol to the membranous fraction with 200 nM PMA (data not shown).
Immunoblotting experiments have shown that adult heart ventricles contain PKCa, d, e and z. No significant difference was observed in the immunoreactive levels and subcellular distribution of these isozymes between lean and obese rats (data not shown). Indeed, in both animal groups the ratio of membrane=cytosolic PKC was 2.0 -2.5 for PKCd and e, while it was 0.5 and 1 for PKCa and z, respectively. As shown by the representative Western blots in Figure 1A , perfusion of isolated hearts from lean Zucker rats with 200 nM PMA for 10 min resulted in a marked increase in immunodetectable ventricular PKCa in the membrane fraction, a response accompanied by a decrease of PKCa, in the cytosolic fraction. This translocation of PKCa, reflecting its activation, was markedly impaired in heart ventricles of obese rats.
Quantitative analysis ( Figure 1B , left panel) showed that perfusion with 200 nM PMA for 10 min induced a significant 2-fold higher increase in ventricular membrane PKCa in hearts from lean rats (321 AE 85% of control) than in those from obese animals (153 AE 21% of control). These PMAinduced increases in membrane PKCa were transient, Obese rat: PMA effect on cardiac glucose metabolism D Morabito et al decreasing to 156 AE 27 and 124 AE 14% for lean and obese rats, respectively, after 30 min of perfusion. Concerning PKCd, e and z, perfusion of isolated hearts with PMA for 10 -30 min had very similar effects in lean and obese rats. The contents of membranous PKCd and e were not affected by PMA, while cytosolic PKCd and e were decreased to 60 -68% and to 39 -44%, respectively, of control values. Not surprisingly, perfusion of hearts with PMA for 10 -30 min had no effect, neither on membranous nor on cytosolic PKCz (data not shown).
PMA-induced translocation of GLUT-4
As shown in Figure 2A , immunoblotting experiments indicated that perfusion of hearts from lean rats with 200 nM PMA for 60 min induced an increase in ventricular sarcolemmal GLUT-4, a response accompanied by a decrease of GLUT-4 in the microsomal fraction. Conversely, there appears to be no effect of PMA treatment on the subcellular distribution of ventricular GLUT-4 in hearts from obese rats.
As illustrated in Figure 2B , densitometric analysis of a series of experiments (n ¼ 3 -5) revealed that in heart ventricles from lean rats, the PMA-induced increase in sarcolemmal GLUT-4 was transient, with GLUT-4 contents increasing to 158% of control values at 60 min and decreasing thereafter. In contrast, perfusion of hearts from obese rats with 200 nM PMA for increasing time-periods (30 -120 min) had no effect on the subcellular distribution of ventricular GLUT-4 ( Figure 2B ).
Mechanical performance of isolated perfused hearts from lean and obese Zucker rats
Data regarding the mechanical performance of the paced hearts are given in Table 1 . As compared to those of lean rats, hearts of obese animals showed a slightly increased diastolic pressure, but there were no statistically significant differences between the two animal groups. Perfusion with increasing concentrations of PMA caused an increase in diastolic pressure at 150 min, when compared to EE-perfused (control) hearts leading to a diminution of the developed left ventricular pressure in both groups of rats (Table 1 ). Obese rat: PMA effect on cardiac glucose metabolism D Morabito et al
Effects of PMA on glucose oxidation and glycolysis in hearts of lean and obese Zucker rats Basal myocardial oxidation rate of glucose was approximately twice as high in lean rats than in obese animals (values after equilibration period were 24 AE 6 and 11 AE 2 nmol=g min for lean and obese rats, respectively; P < 0.005). PMA perfusion of hearts from lean rats caused a significant 25 -40% decrease (MANOVA, P < 0.005) in myocardial glucose oxidation while it had no effect in hearts from obese rats (Figure 3) . Basal glycolysis was found to be approximately 2-fold higher in hearts of lean rats when compared to that of hearts of obese rats (values after equilibration period were 225 AE 53 n and 113 AE 24 nmol=g min for lean and obese rats, respectively; P < 0.05). However, perfusion with increasing concentrations of PMA did not affect basal cardiac glycolysis neither in the hearts of lean rats nor in those of obese animals ( Table 1) .
Discussion
The present data show for the first time that in the PMAperfused heart of lean Zucker rats the activation of ventricular PKCa is accompanied by a translocation of GLUT-4. They further demonstrate that the diminished activation of PKCa observed in the heart of obese Zucker rats is associated with complete suppression of GLUT-4 activation. Our results are in agreement with an earlier study of Van der Werve et al 11 showing that myocardial PKC activation by phorbol ester is impaired in obese Zucker rats when compared to that of lean animals. Hearts were perfused according to the Langendorff method with EE-buffer for an equilibration period of 60 min. Thereafter, perfusion was continued in the absence of PMA (upper part of table) or in the presence of increasing concentrations of PMA (addition of 10 -100 nM, lower part of table). Mechanical performance was recorded and, after an equilibration period of 60 min, samples were taken for analysis as described in Material and methods. Workload was maintained constant at 75 mmHg during the whole duration of the experiments. Results are the mean AE s.e.m. of four to nine independent experiments. *P < 0.05, hearts from fa=fa rats vs hearts from Fa=? rats.
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The role of PKC in the regulation of glucose uptake by recruiting GLUT-4 appears to be cell-and agonist-specific. In skeletal muscle cells PKCz, as well as the DAG-sensitive PKCb 2 and d but not a were found to be involved in the mediation of insulin-induced glucose uptake. 16, 27, 28 On the other hand, in adipocytes PKCz and l, but not PKCa, b 2 , d or e appear to be required for insulin-induced GLUT-4 translocation. 29 The PKC activator PMA was shown to induce GLUT-4 translocation as well as an increased 3-O-methylglucose transport in adipocytes. 30, 31 Conversely, in skeletal muscle cells PMA does not translocate GLUT-4 while increasing glucose uptake. 16 To our knowledge, there is no information concerning the effect of PKC activation on GLUT-4 in the heart. Two studies that investigated the effects of phorbol ester on myocardial glucose transport resulted in controversial findings. Russ and Eckel 32 showed that in ventricular cardiomyocytes PKC activation by PMA had no effect on basal 3-O-methylglucose transport. In contrast to these findings, Van der Werve et al, 8 reported a 3-fold increase in 3-O-methylglucose efflux by PMA in isolated perfused hearts, suggesting stimulation of glucose transport by PKC activation.
In the present study we show that PMA induces the translocation of GLUT-4 from microsomal to sarcolemmal fractions in the heart of lean Zucker rats. By contrast, in PMA-perfused hearts from obese rats subcellular distribution of GLUT-4 remained unchanged. Thus, our results suggest that the cardiac PMA-activated cellular signaling pathway leading to the translocation of GLUT-4 is impaired in obese Zucker rats.
Concerning myocardial glucose oxidation, we found that the basal rate of glucose oxidation was twice as high in lean Zucker rats than in obese animals. Similar observations have been reported by Rösen et al 33 and Crettaz et al.
34
Our data show that in PMA-perfused hearts from lean Zucker rats the basal glucose oxidation rate was diminished by approximately 30%, while glycolysis remained unchanged. Since glucose transport does not represent a rate-limiting step for glucose oxidation, our observations of a PMA-induced activation of GLUT-4 and of a decreased glucose oxidation are not contradictory. Our data are compatible with the interpretation that PMA affects glucose oxidation downstream of glucose transport. A likely candidate would be the pyruvate dehydrogenase (PDH), a multienzymatic complex representing a rate-limiting factor for glucose oxidation. Although in two cell lines (Zajdela hepatoma cells 19 and BC3H-1 myocytes 35 ) PMA has been shown to cause an activation of PDH, it cannot be excluded that in the whole heart activation of PKC could lead to an inhibition of this enzyme. Clearly further studies are necessary to elucidate the role of PKC in the regulation of glucose oxidation in the heart of lean and obese Zucker rats.
The obesity of the homozygote Zucker rat is due to a mutation of the leptin receptor leading to its incapability to transmit leptin signals. The absence of leptin action in the obese Zucker rat could also affect cell signaling and glucose metabolism in these animals. Indeed, leptin has been shown to induce insulin-like effects, such as an increase in glucose uptake. 36 However, leptin has also been found to counteract insulin action. Leptin prevents the insulin induced downregulation of the rate-limiting enzyme of gluconeogenesis, phosphoenolpyruvate carboxy kinase. 37 A perfusion study of pancreatic islets 38 using insulin and PMA suggests that leptin suppresses the second phase of insulin secretion by reducing activation of Ca 2þ -dependent PKC isoforms. In the absence of leptin, other obesity-related factors may affect cellular signaling. One such factor is tumor necrosis factor-a (TNFa), which is overexpressed in adipocytes of obese animals. TNF-a has been shown to inhibit PKC activity but not PKC translocation. 39 TNF-a has also been found to downregulate insulin-induced phosphorylation of insulin receptor substrate-1 (IRS-1) and to reduce insulin-dependent expression of GLUT-4. 40 Thus, it cannot be excluded that a complete absence of leptin action may impair the PKC signaling pathway as well as modulate glucose utilization. Obese rat: PMA effect on cardiac glucose metabolism D Morabito et al Overall, our results indicate that PKCa plays an important role in the regulation of myocardial glucose transport and it can be speculated that the impairment of this regulation in the heart of the obese Zucker rat reflects an early phase in cardiac pathogenesis.
